Adhesin RadD: the secret weapon of Fusobacterium nucleatum

ABSTRACT Fusobacterium nucleatum can promote colorectal cancer (CRC) development through a variety of virulence proteins. Zhang et al. recently identified an adhesin RadD, for Fusobacterium nucleatum adhesion to CRC. Targeting the interaction between RadD and CD147 will provide a new strategy for CRC treatment. This Commentary and View not only summarizes the research highlights but also discusses the possibility of targeted clearance of Fusobacterium nucleatum in clinical applications.

• Publication year

  2024

• Venue

  Gut microbes

• Publication date

  2024-11-09

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1080/19490976.2024.2426617PMID 39520704PMCID 11552248
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The adhesin RadD enhances Fusobacterium nucleatum tumour colonization and colorectal carcinogenesis

  2024cited by this paper
• An emerging antibacterial nanovaccine for enhanced chemotherapy by selectively eliminating tumor-colonizing bacteria.

  2024cited by this paper
• Randomly barcoded transposon mutant libraries for gut commensals II: Applying libraries for functional genetics.

  2023cited by this paper
• Effect of a bacteriocin-producing Streptococcus salivarius on the pathogen Fusobacterium nucleatum in a model of the human distal colon

  2022cited by this paper
• Fusobacterium nucleatum, a key pathogenic factor and microbial biomarker for colorectal cancer.

  2022cited by this paper
• Genetic and molecular determinants of polymicrobial interactions in Fusobacterium nucleatum

  2021cited by this paper
• CD147 receptor is essential for TFF3-mediated signaling regulating colorectal cancer progression

  2021cited by this paper
• Fusobacterium nucleatum host-cell binding and invasion induces IL-8 and CXCL1 secretion that drives colorectal cancer cell migration

  2020cited by this paper
• Metformin elicits antitumour effect by modulation of the gut microbiota and rescues Fusobacterium nucleatum-induced colorectal tumourigenesis

  2020cited by this paper
• Phage-guided modulation of the gut microbiota of mouse models of colorectal cancer augments their responses to chemotherapy

  2019cited by this paper

• The gut microbiome in colorectal cancer: mechanisms of carcinogenesis and emerging microbiota-targeted therapies

  2026cites this paper
• Oral pathogens meet the gut microbiome: new mechanistic insights on systemic disease

  2026cites this paper
• Unraveling the Role of Fusobacterium nucleatum in Colorectal Cancer: Molecular Mechanisms and Pathogenic Insights

  2025cites this paper
• The role of intratumoral microbiome in the occurrence, proliferation, metastasis of colorectal cancer and its underlying therapeutic strategies.

  2025cites this paper
• Targeting Fusobacterium nucleatum in colorectal cancer: therapeutic strategies and future directions

  2025cites this paper
• Unveiling hidden players: the role of intratumoral microbiota in gastrointestinal cancer dynamics

  2025cites this paper